Article Type
Changed
Fri, 01/04/2019 - 11:49
Display Headline
Multiple Myeloma: New Therapies and Changing Cytogenetics

SAN DIEGO Dr. Kenneth C. Anderson, associate editor of The Oncology Report, discusses new therapies for multiple myeloma and changing risk factors in presentations at the 2011 annual meeting of the American Society of Hematology (ASH).

Author and Disclosure Information

Publications
Topics
Legacy Keywords
multiple myeloma therapies, multiple myeloma treatment, myeloma risk factors, cancer treatment, American Society of Hematology
Author and Disclosure Information

Author and Disclosure Information

SAN DIEGO Dr. Kenneth C. Anderson, associate editor of The Oncology Report, discusses new therapies for multiple myeloma and changing risk factors in presentations at the 2011 annual meeting of the American Society of Hematology (ASH).

SAN DIEGO Dr. Kenneth C. Anderson, associate editor of The Oncology Report, discusses new therapies for multiple myeloma and changing risk factors in presentations at the 2011 annual meeting of the American Society of Hematology (ASH).

Publications
Publications
Topics
Article Type
Display Headline
Multiple Myeloma: New Therapies and Changing Cytogenetics
Display Headline
Multiple Myeloma: New Therapies and Changing Cytogenetics
Legacy Keywords
multiple myeloma therapies, multiple myeloma treatment, myeloma risk factors, cancer treatment, American Society of Hematology
Legacy Keywords
multiple myeloma therapies, multiple myeloma treatment, myeloma risk factors, cancer treatment, American Society of Hematology
Article Source

PURLs Copyright

Inside the Article